Martínez-Balsalobre, Elena http://orcid.org/0000-0003-3287-2228
García-Castillo, Jesús http://orcid.org/0000-0002-7520-6746
García-Moreno, Diana
Naranjo-Sánchez, Elena http://orcid.org/0000-0002-5926-5607
Fernández-Lajarín, Miriam
Blasco, María A. http://orcid.org/0000-0002-4211-233X
Alcaraz-Pérez, Francisca http://orcid.org/0000-0003-1802-4943
Mulero, Victoriano http://orcid.org/0000-0001-9527-0211
Cayuela, María L. http://orcid.org/0000-0002-2021-9822
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI19/00188, PI22/00861)
Fundación Ramón Areces Consejeria de Sanidad de la Región de Murcia. ZEBER
Ministry of Science and Innovation. Spain
Article History
Received: 4 October 2021
Accepted: 6 September 2023
First Online: 22 September 2023
Competing interests
: A patent for the use of <i>TERC</i>-based aptamers to treat blood diseases has been registered by the Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria and CIBER-ER (EP20383104). E.M.B., D. G.M., J.G.C., F.A.P., V.M., and M.L.C. are involved in the patent. The other authors declare no competing interests.